Physician profile
Takeshi Seto
NPI 1154323160
$7,102.82
in general payments reported to CMS, 2019-2025
54 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $824 · 2021: $1,002 · 2022: $767 · 2023: $766 · 2024: $871 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,437.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,294.95 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $738.49 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Sunovion Pharmaceuticals INC. | $642.27 | 2019-2021 | |
| Glaxosmithkline, LLC. | $484.95 | 2019-2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $348.88 | 2023-2025 | |
| Genentech USA, INC. | $339.85 | 2019-2025 | Xolair |
| Grifols USA, LLC | $324.65 | 2022-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $300.72 | 2019-2022 | |
| Novo Nordisk INC | $240.20 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Insmed, INC. | $175.50 | 2022-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $174.60 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $158.48 | 2019-2025 | Dupixent, Evkeeza |
| Lilly USA, LLC | $136.62 | 2019-2024 | Mounjaro, Taltz, Zepbound |
| Amgen INC. | $118.33 | 2024-2025 | Tezspire, Enbrel, Evenity |
| Philips North America LLC | $101.58 | 2019-2025 | (8874) Incourage, Encore |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $99.98 | 2019-2024 | |
| Pfizer INC. | $82.72 | 2024-2025 | |
| Viatris Specialty LLC | $81.74 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $81.43 | 2025 | Caplyta |
| Abbvie INC. | $74.79 | 2021-2023 | Dalvance |
| Gilead Sciences, INC. | $71.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $67.93 | 2021 | |
| Eisai INC. | $66.01 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $58.32 | 2025 | Purified Cortrophin Gel |
| Baxter Healthcare | $58.05 | 2022-2025 | Hillrom - Vest System Model 205 Acute Care, Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $54.49 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.84 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $48.53 | 2020-2021 | |
| Exact Sciences Corporation | $44.24 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Averitas Pharma INC. | $41.96 | 2024 | Qutenza |
| Otsuka America Pharmaceutical, INC. | $35.99 | 2024-2025 | Rexulti |
| Phathom Pharmaceuticals, INC. | $33.93 | 2025 | Voquezna |
| Insulet Corporation | $32.97 | 2025 | Omnipod |
| Sanofi Pasteur INC. | $28.82 | 2019-2020 | |
| Amarin Pharma, INC. | $28.56 | 2020-2021 | |
| Boston Scientific Corporation | $28.22 | 2025 | Watchman Flx |
| Jazz Pharmaceuticals INC. | $28.21 | 2025 | |
| Aimmune Therapeutics, INC. | $26.45 | 2025 | Zenpep |
| United Therapeutics Corporation | $25.76 | 2021 | |
| Allergan, INC. | $23.84 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.95 | 2025 | Lifevest |
| Nestle Healthcare Nutrition INC. | $22.60 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.50 | 2023 | Keveyis |
| Hill-Rom Company, INC | $22.05 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.24 | 2023 | Opsumit |
| Tactile Systems Technology INC | $17.65 | 2025 | Flexitouch Plus, Nimbl |
| Axsome Therapeutics, INC. | $16.10 | 2025 | Sunosi |
| Inogen, INC. | $15.96 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $15.65 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $15.30 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.15 | 2021 | |
| Esperion Therapeutics, INC. | $14.67 | 2025 | Nexletol |
| Merck Sharp & Dohme LLC | $14.36 | 2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Daiichi Sankyo INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Takeshi Seto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.